These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21113056)

  • 41. Comparative analysis of dideoxy sequencing, the KRAS StripAssay and pyrosequencing for detection of KRAS mutation.
    Gao J; Li YY; Sun PN; Shen L
    World J Gastroenterol; 2010 Oct; 16(38):4858-64. PubMed ID: 20939116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.
    Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M
    Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer.
    Kristensen LS; Kjeldsen TE; Hager H; Hansen LL
    BMC Cancer; 2012 Nov; 12():548. PubMed ID: 23173730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
    Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. KRAS mutation analysis on cytological specimens of metastatic colo-rectal cancer.
    Troncone G; Malapelle U; Cozzolino I; Palombini L
    Diagn Cytopathol; 2010 Dec; 38(12):869-73. PubMed ID: 20049979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Highly Verified Assay for KRAS Mutation Detection in Tissue and Plasma of Lung, Colorectal, and Pancreatic Cancer.
    Li J; Gan S; Blair A; Min K; Rehage T; Hoeppner C; Halait H; Brophy VH
    Arch Pathol Lab Med; 2019 Feb; 143(2):183-189. PubMed ID: 30088781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology.
    Weichert W; Schewe C; Lehmann A; Sers C; Denkert C; Budczies J; Stenzinger A; Joos H; Landt O; Heiser V; Röcken C; Dietel M
    J Mol Diagn; 2010 Jan; 12(1):35-42. PubMed ID: 20007841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for the detection of K-ras mutations.
    Nordgård O; Oltedal S; Janssen EA; Gilje B; Kørner H; Tjensvoll K; Smaaland R
    Diagn Mol Pathol; 2012 Mar; 21(1):9-13. PubMed ID: 22306670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories.
    Feigelson HS; Goddard KA; Johnson MA; Funk KC; Rahm AK; Kauffman TL; Chitale DA; Le Marchand L; Richards CS
    BMC Res Notes; 2012 Apr; 5():196. PubMed ID: 22534075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A fast, cost-efficient and sensitive approach for KRAS mutation detection using multiplexed primer extension with IP/RP-HPLC separation.
    Tierling S; Sers C; Lehmann A; Walter J
    Int J Cancer; 2012 Feb; 130(3):567-74. PubMed ID: 21387306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis.
    Dijkstra JR; Opdam FJ; Boonyaratanakornkit J; Schönbrunner ER; Shahbazian M; Edsjö A; Hoefler G; Jung A; Kotsinas A; Gorgoulis VG; López-Ríos F; de Stricker K; Rouleau E; Biesmans B; van Krieken JH
    J Mol Diagn; 2012; 14(3):187-91. PubMed ID: 22414609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
    Netzel BC; Grebe SK
    Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KRAS testing in clinical laboratory: optimizing targeted therapy.
    Miravalle L; Lefferts JA; Al-Haddad M; Tsongalis GJ; Cheng L
    Cancer Genomics Proteomics; 2012; 9(5):337-41. PubMed ID: 22990113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer.
    Wang J; Yang H; Shen Y; Wang S; Lin D; Ma L; Han X; Shi Y
    Cancer Biomark; 2013; 13(2):89-97. PubMed ID: 23838137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue.
    Fadhil W; Ibrahem S; Seth R; Ilyas M
    J Clin Pathol; 2010 Feb; 63(2):134-40. PubMed ID: 20154035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The times have changed: molecular pathology is here to stay. A commentary on: analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma, by Lee et al. In this issue.
    van Krieken JH; Hoefler G
    Virchows Arch; 2012 Feb; 460(2):129-30. PubMed ID: 22358180
    [No Abstract]   [Full Text] [Related]  

  • 57. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: a morphology-based approach in colorectal carcinoma.
    Angulo B; García-García E; Martínez R; Suárez-Gauthier A; Conde E; Hidalgo M; López-Ríos F
    J Mol Diagn; 2010 May; 12(3):292-9. PubMed ID: 20203003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
    Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applicability of a System for fully automated nucleic acid extraction from formalin-fixed paraffin-embedded sections for routine KRAS mutation testing.
    Lehmann A; Schewe C; Hennig G; Denkert C; Weichert W; Budczies J; Dietel M
    Diagn Mol Pathol; 2012 Jun; 21(2):114-9. PubMed ID: 22555094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China.
    Zhang R; Han Y; Huang J; Ma L; Li Y; Li J
    Clin Chem Lab Med; 2014 Dec; 52(12):1851-7. PubMed ID: 24945428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.